Home » Authors » James Etheridge

Articles by James Etheridge

Synt:em Raises EUR22M To Support Product Development

March 21, 2001

By James Etheridge

Key Departure, Financials Send Genset's Stock Price Tumbling

March 14, 2001

By James Etheridge

Key Departure, Financials Send Genset's Stock Price Tumbling

March 14, 2001

By James Etheridge

DrugAbuse Reports Positive Phase II Results Of Naltrel

Feb. 21, 2001

By James Etheridge

DrugAbuse Reports Positive Phase II Results Of Naltrel

Feb. 21, 2001

By James Etheridge

Despite Resistance In France, Chirac Sees Place For GM Crops

Feb. 14, 2001

By James Etheridge

Hybrigenics, Servier Collaborate On Discovery Of Cancer Drugs

Feb. 14, 2001

By James Etheridge

Genset Cuts Back Genomics Focus, Moves On To Discovery

Feb. 14, 2001

By James Etheridge

French Advancing Legislation To Allow Therapeutic Cloning

Feb. 14, 2001

By James Etheridge

Despite Resistance In France, Chirac Sees Place For GM Crops

Feb. 14, 2001

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.